Establishment and characterization of a novel human immature megakaryoblastic leukemia cell line, M-MOK, dependent on fibroblasts for its viability.

Manatsu Itano(Tohoku University), T. Koike, Naoko Minegishi(Tohoku Medical Megabank Organization), Shiho T. Morita, Soken Tsuchiya(Kumamoto University), Takaaki Yambe, Y. Ohashi, Hiromi Fujie, Takahiro Masuda(Jichi Medical University), Masayoshi Minegishi

PubMed

November 1, 1995

Cited by 14

Related Papers

Genome-wide association study identifies 112 new loci for body mass index in the Japanese population

|Nature Genetics|2017|510

SGLT2 inhibitor empagliflozin reduces renal growth and albuminuria in proportion to hyperglycemia and prevents glomerular hyperfiltration in diabetic Akita mice

|American Journal of Physiology-Renal Physiology|2013|481

The Tohoku Medical Megabank Project: Design and Mission

|Journal of Epidemiology|2016|386

Increase in SGLT1-mediated transport explains renal glucose reabsorption during genetic and pharmacological SGLT2 inhibition in euglycemia

|American Journal of Physiology-Renal Physiology|2013|308

Cohort Profile: Tohoku Medical Megabank Project Birth and Three-Generation Cohort Study (TMM BirThree Cohort Study): rationale, progress and perspective

|International Journal of Epidemiology|2019|201